1. Home
  2. BLND vs CTKB Comparison

BLND vs CTKB Comparison

Compare BLND & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLND
  • CTKB
  • Stock Information
  • Founded
  • BLND 2012
  • CTKB 1990
  • Country
  • BLND United States
  • CTKB United States
  • Employees
  • BLND N/A
  • CTKB N/A
  • Industry
  • BLND EDP Services
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • BLND Technology
  • CTKB Health Care
  • Exchange
  • BLND Nasdaq
  • CTKB Nasdaq
  • Market Cap
  • BLND 625.9M
  • CTKB 708.8M
  • IPO Year
  • BLND 2021
  • CTKB 2021
  • Fundamental
  • Price
  • BLND $3.33
  • CTKB $5.14
  • Analyst Decision
  • BLND Buy
  • CTKB Buy
  • Analyst Count
  • BLND 6
  • CTKB 4
  • Target Price
  • BLND $3.58
  • CTKB $8.50
  • AVG Volume (30 Days)
  • BLND 1.6M
  • CTKB 476.3K
  • Earning Date
  • BLND 11-05-2024
  • CTKB 11-05-2024
  • Dividend Yield
  • BLND N/A
  • CTKB N/A
  • EPS Growth
  • BLND N/A
  • CTKB N/A
  • EPS
  • BLND N/A
  • CTKB N/A
  • Revenue
  • BLND $152,122,000.00
  • CTKB $197,711,000.00
  • Revenue This Year
  • BLND $4.74
  • CTKB $7.94
  • Revenue Next Year
  • BLND $25.20
  • CTKB $15.93
  • P/E Ratio
  • BLND N/A
  • CTKB N/A
  • Revenue Growth
  • BLND N/A
  • CTKB 12.60
  • 52 Week Low
  • BLND $1.15
  • CTKB $3.80
  • 52 Week High
  • BLND $4.25
  • CTKB $9.87
  • Technical
  • Relative Strength Index (RSI)
  • BLND 39.51
  • CTKB 47.49
  • Support Level
  • BLND $3.38
  • CTKB $5.12
  • Resistance Level
  • BLND $3.97
  • CTKB $5.47
  • Average True Range (ATR)
  • BLND 0.19
  • CTKB 0.22
  • MACD
  • BLND -0.03
  • CTKB 0.02
  • Stochastic Oscillator
  • BLND 0.77
  • CTKB 51.11

About BLND Blend Labs Inc.

Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segments are; Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience, and the Title segment enables customers to streamline the title, settlement, and closing process at scale for mortgages, home equity lines of credit, and home equity loans. The majority of the revenue for the company is generated from the Blend Platform segment.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: